ProfileGDS4718 / 212381_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 79% 69% 67% 68% 75% 74% 74% 71% 64% 73% 79% 65% 79% 80% 76% 79% 74% 76% 74% 65% 73% 73% 70% 73% 76% 71% 67% 74% 71% 76% 75% 71% 64% 73% 70% 70% 73% 67% 66% 71% 71% 75% 65% 82% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.6918479
GSM549102patient 115, normal, homogenized [OPG study]6.8040869
GSM549104patient 119, normal, homogenized [OPG study]6.6637167
GSM549108patient 138, normal, homogenized [OPG study]6.6959168
GSM549119patient 077, normal, homogenized [OPG study]7.2784275
GSM549133patient 032, cancer, homogenized [OPG study]7.3374874
GSM549139patient 042, cancer, homogenized [OPG study]7.3149274
GSM549099patient 107, normal, homogenized [OPG study]6.9200571
GSM549109patient 139, normal, homogenized [OPG study]6.4310464
GSM549110patient 046, normal, homogenized [OPG study]7.0791373
GSM549114patient 063, normal, homogenized [OPG study]7.7861879
GSM549122patient 082, normal, homogenized [OPG study]6.4659965
GSM549134patient 033, cancer, homogenized [OPG study]7.7416879
GSM549136patient 036, cancer, homogenized [OPG study]7.9633480
GSM549140patient 044, cancer, homogenized [OPG study]7.5605576
GSM549111patient 047, normal, homogenized [OPG study]7.7479
GSM549113patient 057, normal, homogenized [OPG study]7.308174
GSM549132patient 031, cancer, homogenized [OPG study]7.4914876
GSM549137patient 038, cancer, homogenized [OPG study]7.2755174
GSM549142patient 047, cancer, homogenized [OPG study]6.4979265
GSM549100patient 110, normal, homogenized [OPG study]7.0718373
GSM549107patient 135, normal, homogenized [OPG study]7.1757973
GSM549115patient 068, normal, homogenized [OPG study]6.9180370
GSM549116patient 072, normal, homogenized [OPG study]7.2078173
GSM549120patient 078, normal, homogenized [OPG study]7.4140376
GSM549131patient 030, cancer, homogenized [OPG study]7.0325171
GSM549118patient 074, normal, homogenized [OPG study]6.6300267
GSM549129patient 027, cancer, homogenized [OPG study]7.3163574
GSM549123patient 088, normal, homogenized [OPG study]6.9740971
GSM549124patient 006, cancer, homogenized [OPG study]7.3648776
GSM549126patient 015, cancer, homogenized [OPG study]7.3496375
GSM549128patient 025, cancer, homogenized [OPG study]7.0534271
GSM549103patient 117, normal, homogenized [OPG study]6.4233964
GSM549117patient 073, normal, homogenized [OPG study]7.158673
GSM549138patient 041, cancer, homogenized [OPG study]6.8833470
GSM549141patient 045, cancer, homogenized [OPG study]6.9323870
GSM549130patient 028, cancer, homogenized [OPG study]7.1643373
GSM549101patient 111, normal, homogenized [OPG study]6.6695867
GSM549105patient 128, normal, homogenized [OPG study]6.5849166
GSM549106patient 134, normal, homogenized [OPG study]7.0512271
GSM549112patient 048, normal, homogenized [OPG study]6.9438371
GSM549125patient 011, cancer, homogenized [OPG study]7.2933575
GSM549127patient 024, cancer, homogenized [OPG study]6.5258965
GSM549135patient 035, cancer, homogenized [OPG study]8.161482